Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization--SST Report No. 1
- PMID: 12695250
- PMCID: PMC1434793
- DOI: 10.1001/archopht.121.4.531
Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization--SST Report No. 1
Erratum in
- Arch Ophthalmol. 2003 Oct;121(10):1513
Abstract
Background: The National Eye Institute Visual Function Questionnaire (NEI-VFQ) measures vision-targeted quality of life, but it is unclear whether it is sensitive to changes within individuals over time.
Objective: To determine the responsiveness of the NEI-VFQ to "within-individual" changes in visual acuity in patients who had subfoveal choroidal neovascularization in at least one eye secondary to age-related macular degeneration, ocular histoplasmosis syndrome, or idiopathic causes, and who participated in randomized trials of submacular surgery.
Methods: Trained telephone interviewers administered the NEI-VFQ as part of annual follow-up data collection for pilot trials and larger clinical trials of submacular surgery. Best-corrected visual acuity was measured by local vision examiners at 12 months after enrollment and, typically, by central "traveling" vision examiners at 24 months after enrollment. Changes in visual acuity and NEI-VFQ scores from 12 to 24 months were analyzed using linear regression methods.
Results: Two-hundred eighteen patients had both interviews and visual acuity measurements at 12 and 24 months after enrollment. Changes in the overall NEI-VFQ score and in 9 of the subscales (near activities, dependency, driving, role difficulties, distance activities, mental health, general vision, peripheral vision, and social functioning) were related to changes in visual acuity of the better-seeing eye based on linear regression analysis (P<.05). In our analysis, a 3-line decrease in the visual acuity of the better-seeing eye was associated with 3.6- to 16.2-point decreases in the overall NEI-VFQ score and 9 subscale scores.
Conclusions: Most of the NEI-VFQ subscales were responsive to changes in the visual acuity of the better-seeing eye over a 12-month interval in this patient population. Thus, the NEI-VFQ can be used to measure change in vision-targeted quality of life over time to augment clinical measurements of visual acuity.
Figures




Similar articles
-
Evaluation of minimum clinically meaningful changes in scores on the National Eye Institute Visual Function Questionnaire (NEI-VFQ) SST Report Number 19.Ophthalmic Epidemiol. 2007 Jul-Aug;14(4):205-15. doi: 10.1080/09286580701502970. Ophthalmic Epidemiol. 2007. PMID: 17896299
-
Health- and vision-related quality of life among patients with ocular histoplasmosis or idiopathic choroidal neovascularization at enrollment in a randomized trial of submacular surgery: Submacular Surgery Trials Report No. 5.Arch Ophthalmol. 2005 Jan;123(1):78-88. doi: 10.1001/archopht.123.1.78. Arch Ophthalmol. 2005. PMID: 15642816 Free PMC article. Clinical Trial.
-
Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: II. Quality-of-life findings from a randomized clinical trial: SST Group H Trial: SST Report No. 10.Arch Ophthalmol. 2004 Nov;122(11):1616-28. doi: 10.1001/archopht.122.11.1616. Arch Ophthalmol. 2004. PMID: 15534122 Free PMC article. Clinical Trial.
-
Surgical removal of subfoveal choroidal neovascularization without removal of posterior hyaloid: a consecutive series in younger patients.Retina. 2001;21(4):317-23. doi: 10.1097/00006982-200108000-00004. Retina. 2001. PMID: 11508876 Review.
-
New and classic insights into presumed ocular histoplasmosis syndrome and its treatment.Curr Opin Ophthalmol. 2005 Jun;16(3):160-5. doi: 10.1097/01.icu.0000161228.21797.d9. Curr Opin Ophthalmol. 2005. PMID: 15870572 Review.
Cited by
-
Three-year follow-up of visual outcome and quality of life in patients with age-related macular degeneration.Clin Ophthalmol. 2013;7:395-401. doi: 10.2147/OPTH.S41585. Epub 2013 Feb 27. Clin Ophthalmol. 2013. PMID: 23467557 Free PMC article.
-
Six and eight weeks injection frequencies of bevacizumab are non-inferior to the current four weeks injection frequency for quality of life in neovascular age-related macular degeneration: a randomized controlled trial.Qual Life Res. 2020 Dec;29(12):3305-3313. doi: 10.1007/s11136-020-02580-9. Epub 2020 Jul 14. Qual Life Res. 2020. PMID: 32666333 Free PMC article. Clinical Trial.
-
Quality of life in a prospective, randomised pilot-trial of photodynamic therapy versus full macular translocation in treatment of neovascular age-related macular degeneration--a report of 1 year results.Graefes Arch Clin Exp Ophthalmol. 2007 Dec;245(12):1831-6. doi: 10.1007/s00417-007-0558-9. Epub 2007 Mar 9. Graefes Arch Clin Exp Ophthalmol. 2007. PMID: 17347809 Clinical Trial.
-
Longitudinal changes in visual acuity and health-related quality of life: the Los Angeles Latino Eye study.Ophthalmology. 2010 Oct;117(10):1900-7, 1907.e1. doi: 10.1016/j.ophtha.2010.01.059. Epub 2010 Jun 8. Ophthalmology. 2010. PMID: 20570364 Free PMC article.
-
Is the NEI-VFQ-25 a useful tool in identifying visual impairment in an elderly population?BMC Ophthalmol. 2006 Jun 9;6:24. doi: 10.1186/1471-2415-6-24. BMC Ophthalmol. 2006. PMID: 16764714 Free PMC article.
References
-
- Mangione CM, Berry S, Spritzer K, et al. Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol. 1998;116:227–233. - PubMed
-
- Mangione CM, Lee PP, Pitts J, et al. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ) Arch Ophthalmol. 1998;116:1496–1504. - PubMed
-
- Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119:1050–1058. - PubMed
-
- Broman AT, Munoz B, West SK, et al. Psychometric properties of the 25-item NEI-VFQ in a Hispanic population: proyecto VER. Invest Ophthalmol Vis Sci. 2001;42:606–613. - PubMed
-
- Cole SR, Beck RW, Moke PS, Gal RL, Long DT the Optic Neuritis Study Group. The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Invest Ophthalmol Vis Sci. 2000;41:1017–1021. - PubMed